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Abstract The aim of this study was to investigate whether
tumor cells as well as tumor-associated macrophages
(TAMs) contribute to the generation of protease activities
essential to tumor cell invasiveness, such as matrix
metalloproteinase 2 and 9 (MMP-2 and MMP-9), and the
urokinase-type plasminogen activator (uPA) and uPA
receptor (uPAR). We found that the enhanced invasiveness
through Matrigel-coated filters of B16 murine melanoma
cells stimulated with IFNc was associated with an higher
expression of uPAR and MMP-9 in these cells. Moreover,
treatment with anti-MMP-9 or anti-uPAR monoclonal
antibodies abrogated the increase of invasiveness in IFNc-
stimulated melanoma cells, suggesting a cooperation of
uPA system and MMP-9 in cytokine-stimulated invasive-
ness. Invasiveness through Matrigel was also enhanced in
B16 melanoma cells exposed to a medium conditioned by
TAMs, represented in our experimental model by thiogly-
collate-elicited macrophages co-cultivated with melanoma
cells. Macrophages isolated from these co-cultures were
found to express higher levels of uPAR and MMP-9
compared to macrophage cultures alone, and the pro-inva-
sive activity of the co-culture-conditioned medium was
abrogated by anti-MMP-9 monoclonal antibodies, but not
anti-uPAR monoclonal antibodies. Furthermore, the
enhanced uPAR and MMP-9 expression in macrophages co-
cultivated with tumor cells seems a rather specific phenom-
enon, generated through a cell-to-cell contact mechanism.
On the whole, our data point to a cooperation between tumor
cells and macrophages elicited by tumor cells themselves in
generating key enzymes essential in the promotion of tumor
invasiveness, such as uPAR and MMP-9.
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Introduction
It is well established that the transition from a non-invasive
to an invasive phenotype in tumor cells is associated with
several molecular changes, including an enhanced expres-
sion of different families of proteases, e.g. MMP-2 and
MMP-9, and uPA system (uPA/uPAR) [1–5].
Both families of proteases are markers of melanoma
progression. Indeed, uPA/uPAR and MMPs are expressed in
advanced stages of primary and metastatic melanoma lesions
[6–8]. Moreover, antisense oligodeoxynucleotides for uPAR
inhibit invasion and metastatic diffusion in a human mela-
noma line [9], while the inhibition of MMP expression by
genetic [10] and pharmacological [11] approaches blocked
the invasiveness of murine melanoma cells.
Different types of host cells, e.g. infiltrating lymphocytes
and macrophages, are known to be present in the tumoral
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microenvironment [12, 13]. Although, a role in host defense
mechanisms against malignancy has been attributed to these
cells [14], increasing evidences suggest, however, that
tumor-associated macrophages (TAMs) may secrete vari-
ous protease activities promoting the invasiveness of tumor
cells [15–18]. In particular, metastatic dissemination of a
mammary cancer was reduced in colony stimulating factor-
deficient mice, a condition that impairs the recruitment of
macrophages into the tumoral microenvironment [19].
In the present study, we explored the possibility that
MMP-2, MMP-9 and uPA system are the effectors of the
enhanced invasiveness expressed by B16 murine melanoma
cells stimulated with IFNc, that we reported in a previous
paper [20]. We also investigated whether the enhancement of
invasive properties observed in B16 melanoma cells stimu-
lated by activated macrophages [15] is related to a release of
MMP-2, MMP-9 and uPA system by these latter. To this aim,
we determined MMPs and uPA system in the medium con-
ditioned by thioglycollate-elicited murine peritoneal
macrophages co-cultivated with a low metastatic clone iso-
lated from B16-F10 melanoma line, the F10-M3 cells.
Materials and methods
Cell lines and culture conditions
In this study, we used a low metastatic clone of B16-F10
murine melanoma line, the F10-M3 cells [21], primary cul-
tures of murine fibroblasts isolated in our laboratory from
C57Bl/6 mice and HT1080 human fibrosarcoma cells
(ATCC, Rockville, MD). Cells were grown in Dulbecco’s
modified Eagle medium containing 4500 mg/l glucose
(DMEM 4500, GIBCO) supplemented with 10% fetal calf
serum (FCS) (Boerhinger Mannheim, Germany), at 37C in a
10 % CO2-humidified atmosphere. 5.0 9 10
5 cells were
seeded in 100 mm Falcon dishes and propagated every
3 days by incubation with a trypsin-EDTA solution (GIB-
CO). Cultures were periodically monitored for mycoplasma
contamination using Chen’s fluorochrome test [22]. In some
experiments, F10-M3 murine melanoma cells were grown
for 24 h in a medium supplemented with IFNc (25–100 U/
ml) (Peprotech, England), in the presence or absence of JAK
inhibitor I (500 nM) or AG490 (500 nM) (Calbiochem).
Preparation of co-cultures of macrophages with murine
melanoma cells or normal fibroblasts
Cultures of macrophages were established from peritoneal
exudates collected by lavage from 6–8 week-old C57Bl/6
mice that had been injected intraperitoneally with 1 ml of
3% thioglycollate broth (Sigma) 3–4 days before, as
reported in a previous paper [15]. 1:1 co-cultures were
prepared by seeding F10-M3 melanoma cell or normal
fibroblast suspensions on macrophage monolayers, at the
density of 250 9 103 cells/cm2. Macrophage cultures and
macrophage co-cultures were incubated in a DMEM med-
ium containing 250 lg/ml BSA (DMEM/BSA), at 37C, in
a 10 % CO2-humidified atmosphere. After 24 h, tumor cells
or normal fibroblasts were removed from the macrophage
co-cultures by incubation with a trypsin-EDTA solution. By
using anti-S-100 mAb, we found that less than 0.1% of cells
contained in macrophage preparations was represented by
tumor cells.
Total RNA extraction, cDNA synthesis and PCR
amplification
Total RNA was extracted from macrophages, macrophages
exposed to tumor cells or normal fibroblasts, tumor cells and
normal fibroblasts using RNAagent (Total RNA Isolation
System, Promega, Madison, WI). The RNA concentration
was determined by a spectrophotometer reading at 260 and
280 nm. Complementary DNA (cDNA) was synthesized
from 1 lg of total RNA using 4 U/ll of M-MLV reverse
transcriptase (Promega). Aliquots of 5 ll of the cDNA were
used for PCR amplification. The specific primers used for the
identification of murine uPA, uPAR, MMP-2, MMP-9, b2-
microglobulin were: uPA (sense: 50-TAT-GCA-GCC-CT
A-TGG-CTC-30; antisense: 50-GAA-GTG-TGA-GAC-CC
T-GTG-TAG-AC-30, 210 bp product); uPAR (sense: 50-GG
A-CTC-CCA-AGG-CGG-CTG-CTG-C-30; antisense: 50-G
GG-CCA-CCA-TTG-CAG-TGG-GTG-30, 598 bp product);
MMP-2 (sense: 50-AGA-GAC-CTC-AGG-GTG-ACA-C-30;
antisense: 50-AAG-AAG-TTG-TAG-TTG-GCC-A-30, 330
bp product); MMP-9 (sense: 50-GCT-CCT-GGC-TCT-CCT-
GGC-TT-30; antisense: 50-GTC-CCA-CTT-GAG-GCC-TT
T-GA-30, 331 bp product) and b2-microglobulin (sense: 50-T
GC-TAT-CCA-GAA-AAC-CCC-TC-30; antisense: 50-GTC-
ATG-CTT-AAC-TCT-GCA-GG-30, 258 bp product) [23].
All PCR reactions were performed using 0.1 U/ll of Go-Taq
Polymerase (Promega). Amplification was carried out on a
Perkin-Elmer Thermal cycler. Ten microliters of each PCR
product were visualized after electrophoresis in a 2% agarose
gel containing ethidium bromide 0.5 lg/ml. cDNA products
were evaluated on the basis of a standard PCR marker
(Promega).
Zymography
The gelatinolytic activity released by macrophages, mac-
rophage:tumor cell co-cultures and tumor cells into their
respective growth medium was tested by means of
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electrophoresis on a 8% SDS-PAGE gels co-polymerized
with 0.1% (w/v) type A gelatin (Sigma). Gels were washed
for 30 min in 2.5% (v/v) Triton X-100 (Sigma) in order to
remove SDS, and then incubated for 24 h at 37 C in
50 mM Tris–HCl, pH 7.4, containing 200 mM NaCl and
5 mM CaCl2. In order to visualize the zone of lysis, the
gels were stained for 60 min at room temperature with
0.1% Coomassie brilliant blue (Merck), and destained for
2 h in a solution of methanol/acetic acid/water (3:1:6; v/v).
The gelatinolytic activity was demonstrated as clear bands
on a blue background. Moreover, the gelatinolytic activi-
ties of HT1080 human fibrosarcoma cells were used as
markers of molecular weight.
Invasion assay
Invasiveness of F10-M3 melanoma cells was determined
on Matrigel-coated polycarbonate filters (8 lm pore size)
mounted in Boyden’s chambers. The coated filters were
prepared by using Matrigel suspensions at 250 lg/ml.
25 9 103 F10-M3 melanoma cells suspended in 200 ll
DMEM 4500 containing 250 lg/ml BSA (DMEM/BSA)
were seeded in upper chamber and incubated for 18–24 h.
After incubation, cells on the upper side of the filters were
wiped off and the membranes were fixed overnight in ice-
cold methanol. Cells on the lower side of the membranes
were stained with Diff Quick and counted.
Migration of F10-M3 murine melanoma cells was eval-
uated in cells grown in DMEM 4500 supplemented with
FCS and then resuspended in: (a) a macrophage conditioned
medium; (b) a medium conditioned by macrophage:tumor
cell co-cultures; (c) a medium conditioned by macro-
phage:fibroblast co-cultures; (d) a medium conditioned by
macrophage:tumor cell co-cultures supplemented with anti-
MMP-9 monoclonal antibodies (17.5 lg/ml, final concen-
tration) (AB19047, Chemicon, USA); and (e) a medium
conditioned by macrophages co-cultivated with tumor cells
in the presence of anti-uPAR monoclonal antibodies
(26 lg/ml, final concentration) (MAB531, R&D System).
F10-M3 murine melanoma cells grown in a standard med-
ium, and then migrated in a fresh DMEM/BSA medium,
were used as a control.
Western blotting analysis
Cells or macrophages were washed with ice cold PBS con-
taining 1 mM Na4VO3, and lysed in 100 ll of cell lysis
buffer containing: 20 mM Tris–HCl (pH 7.4), 150 mM
NaCl, 100 mM HEPES, 1% Triton X-100, 10 mM glycer-
ophosphate, 100 lM PMSF, 100 mM AEBSF, 5 mM
bestatin, 2 mM leupeptin, 1 mM pepstatin A, and 80 lM of
aprotinin, 1.5 mM E-64. Aliquots of supernatants containing
equal amounts of protein (25 lg) in Laemmli buffer were
separated on 8% (v/v) SDS-PAGE gel. Fractionated proteins
were transferred from the gel to a PVDF nitrocellulose
membrane using an electroblotting apparatus (Bio-Rad).
Blots were stained with Ponceau red to ensure equal loading
and complete transfer of proteins, and then blocked for 1 h,
at room temperature, with Odyssey blocking buffer (M-
Medical). Subsequently, the membrane was probed at 4C
overnight with goat anti-mouse uPAR monoclonal anti-
bodies (R&D Systems) diluted in a solution of 1:1 Odyssey
blocking buffer/T-PBS buffer. The membrane was washed
in T-PBS buffer, incubated for 1 h at room temperature with
a rabbit anti-goat Alexa Flour 680 antibodies (Invitrogen)
(dilution 1:7,000 in Odyssey blocking buffer), and then
visualized by an Odyssey Infrared Imaging System (LI-COR
Bioscience). Rabbit anti-murine b-actin (Santa Cruz)
monoclonal antibodies, diluted 1:10000 in T-PBS, were used
to assess equal amount of protein loaded in each lane.
Statistical analysis
The statistical significance of the differences was determined
using Student’s t-test, and defined a p \ 0.05. Invasion
assays were done in triplicate in at least two-three different
experiments. Data are expressed as means ± SEM.
Results
Change of invasiveness and protease expression in
IFNc-stimulated F10-M3 murine melanoma cells
Figure 1 (panel a) shows that 100 U/ml of IFNc stimulated
invasiveness of F10-M3 murine melanoma cells through
Matrigel-coated filters. Moreover, treatment of IFNc-
stimulated tumor cells with JAK inhibitor-I or with AG490,
two well known inhibitors of JAK1 and JAK2 signal
transduction factors [24, 25], prevented the pro-invasive
activity of IFNc on cell invasion. As shown in Fig. 1 (panel
b), 100 U/ml of IFNc stimulated mRNA expression for
uPAR and MMP-9 in melanoma cells. The increase of
invasiveness through Matrigel of IFNc-stimulated mela-
noma cells was prevented in the presence of a migration
medium supplemented with anti-uPAR or anti-MMP-9
monoclonal antibodies (Fig. 1, panel c).
Change of MMPs and uPA/uPAR expression in
thioglycollate-elicited macrophages after co-cultivation
with syngeneic F10-M3 melanoma cells
As shown in Fig. 2 (panel a), thioglycollate-elicited mac-
rophages expressed higher levels of mRNAs for uPA,
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uPAR, MMP-9 and MMP-2 following stimulation with
IFNc/LPS, a behaviour reflecting a state of ‘‘responsive’’
macrophages [26]. Macrophages expressed higher levels of
mRNAs for uPAR and MMP-9, once co-cultivated with
F10-M3 murine melanoma cells, and an higher pro-MMP-9
activity was found in the growth medium of macrophage:
tumor cell co-cultures (Fig. 2, panel b). The higher level of
mRNA for uPAR found in macrophages co-cultivated with
tumor cells was also accompanied by an increased level of
uPAR protein (Fig. 3, panel c). The up-regulation of uPAR
and MMP-9 expression in macrophages co-cultivated with
tumor cells seemed to be a phenomenon independent of
soluble factors secreted by melanoma cells, but rather
related to macrophage/melanoma cell contact. In fact, we
did not find any change in mRNA expression for uPAR and
MMP-9 in macrophages either cultivated in transwell
plates with F10-M3 melanoma cells, or grown in a medium
conditioned by melanoma cells themselves (Fig. 2, panel
d). Furthermore, the promoting activity of melanoma cells
on the expression of macrophage proteases appeared to be
rather specific, in view of the finding that macrophages
cultivated with normal murine fibroblasts expressed the
same low levels of mRNA for uPAR and MMP-9 as those
shown by macrophages grown in a standard medium
(Fig. 2, panel e).
Change of invasiveness in F10-M3 murine melanoma
cells exposed to a medium conditioned by macrophage:
tumor cell co-cultures
As shown in Fig. 3 (panel a), F10-M3 murine melanoma
cells became more invasive through Matrigel when they
were tested in the presence of a medium conditioned by
macrophage: tumor cell co-cultures, an effect that was
abrogated by anti-MMP-9 monoclonal antibodies. On the
other hand, the invasiveness through Matrigel was
unchanged in melanoma cells tested in the presence of a
medium conditioned by macrophage: fibroblast co-cul-
tures, both in the absence or in the presence of anti-MMP-9
monoclonal antibodies. As shown in Fig. 3 (panel b), a
medium conditioned by macrophages co-cultivated with
melanoma cells in the presence of anti-uPAR monoclonal
antibodies for the entire period of co-cultivation failed to
enhance the invasiveness of melanoma cells. This finding
ruled out the possibility that uPA system stimulates MMP-
9 activation in macrophages grown together with tumor
cells. Western blotting analysis showed an increase extra-
cellular-signal regulated kinase (ERK1/2) in macrophages
co-cultivated with tumor cells, that was abrogated by mAb
anti-uPAR (see box in Fig. 3, panel b).
Discussion
The present study shows that IFNc-stimulated invasiveness
of F10-M3 murine melanoma cells is associated with a
greater expression of uPAR and MMP-9. Moreover, the
IFNc-stimulated invasiveness was blocked by treatment
with monoclonal antibodies anti-uPAR or anti-MMP-9,
suggesting a role of uPA and MMP-9 in the pro-invasive
activity of IFNc. A cooperation between uPA system and
MMP-9 was reported for intravasation of cancer cells of a
different origin [27]. In addition, the invasion and meta-
static diffusion of glioblastoma cells was prevented by the
use of small interfering RNA expression vectors for uPAR
and MMP-9 [28]. These results are in agreement with the
finding that patients with pancreatic tumors expressing
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Fig. 1 Abrogation of invasiveness in IFNc-stimulated F10-M3
murine melanoma cells challenged with anti-uPAR or anti-MMP-9
monoclonal antibodies. (a) Invasiveness of tumor cells stimulated
with 100 U/ml of IFNc in the presence of JAK inhibitor I (500 nM) or
AG490 (500 nM). (b) RT-PCR analysis of mRNA for uPA/uPAR and
MMPs in tumor cells stimulated with 100 U/ml of IFNc(representa-
tive gel of 3–4 independent experiments). (c) Change in invasiveness
in IFNc-stimulated tumor cells re-suspended in a migration medium
(DMEM/BSA) containing anti-uPAR or anti-MMP-9 monoclonal
antibodies. *Significantly different from cells grown in a standard
medium and migrated in DMEM/BSA, at p \ 0.05
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high levels of uPA and MMP-9 had a shorter survival time
[29].
The present study also shows that murine melanoma
cells expressed a greater invasiveness through Matrigel,
when migration assay was performed in the presence of a
medium conditioned by macrophages co-cultivated with
tumor cells. This phenomenon was found to be associated
with an increased expression of uPAR and MMP-9 in
macrophages isolated from tumor cells. However, by the
use of monoclonal antibodies we found that the enhanced
invasiveness of melanoma cells exposed to a medium
conditioned by macrophage: tumor cell co-cultures was
dependent on MMP-9, but not on uPAR. Preliminary
experiments showed that other protease activities secreted
by macrophages and/or tumor cells are implicated in the
activation of MMP-9 in macrophages co-cultivated with
melanoma cells. Indeed, a medium conditioned by mac-
rophages co-cultivated with tumor cells in the presence of a
cocktail of inhibitors for aspartic, cysteine and serine
protease, failed to stimulate invasiveness through Matrigel
in melanoma cells (data not shown). In view of the signal
transduction functions of uPAR [5], we verified whether
the enhanced expression of uPAR in macrophages
co-cultivated with tumor cells was associated with a
change of ERK. By the use of a anti-uPAR mAb, we found
an association between the enhanced expression of uPAR
and an enhancement of ERK1/2 in macrophages co-culti-
vated with melanoma cells. uPAR and MMP-9 expression
in macrophages co-cultivated with tumor cells seems a
rather specific phenomenon, probably evoked by a cell-to-
cell contact mechanism. Histopathological studies revealed
a tight contact between macrophages and tumor cells at the
invasive edges of tumors [30, 31].
The contribution of stromal-derived MMPs to mela-
noma progression was supported by the observation that
injection of B16 melanoma cells into the tail vein of MMP-
2 and MMP-9 null mice led to a significant decrease in the
number of lung metastases compared to that found in mice
expressing MMPs [32]. Moreover, a lower incidence of
tumors was found in the peritoneal cavity of immunodefi-
cient MMP-9 null mice transplanted with human ovarian
cancer cells [33]. It has been reported that MMP-9-
expressing TAMs promote secondary organ colonization of
human and murine tumor cells [34].
On the whole, our data revealed that uPAR and MMP-9
are generated by cytokine-stimulated murine melanoma
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9 and MMP-2 in macrophages co-cultivated with tumor cells, in
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cells as well as macrophages elicited by melanoma cells
themselves, as a result of the reciprocal interaction between
the two types of cells. This finding suggests that redundant
mechanisms operating in the tumor inflammatory micro-
environment are responsible of the transition of tumor cells
to an invasive phenotype. Thus, beside tumor cells, host
inflammatory cells should also be considered as targets in
the therapeutic approach of cancer.
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